Investing
Bristol Myers to buy RayzeBio for about $4.1 billion
© Reuters. FILE PHOTO: A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo
(Reuters) – Bristol Myers (NYSE:) Squibb said on Tuesday it would buy RayzeBio for about $4.1 billion to bolster its cancer drug business, marking the second large deal struck by the drugmaker in less than a week.
With the deal, Bristol will gain access to RayzeBio’s late-stage targeted cancer therapy, RYZ101, which works by combining radioactive particles that kill cells with molecules that attach themselves to the tumors.
The U.S. drugmaker is turning to deals at a time when two of its top drugs, blood cancer treatment Revlimid and blood thinner Eliquis, face generic competition.
Its other top seller, cancer immunotherapy Opdivo, is also expected to face revenue loss as the drug will lose patent protection later this decade.
The drugmaker had announced a $14 billion buyout of schizophrenia drug developer Karuna Therapeutics (NASDAQ:) on Friday, gaining a promising new type of antipsychotic medicine to help power growth.
Bristol said it will pay $62.50 for each share of RayzeBio in cash, representing a premium of 104% to the stock’s last close.
RayzeBio shares nearly doubled to $60.9 in premarket trading.
Bristol said it expects to finance the transaction primarily with new debt. The deal is expected to reduce its adjusted profit per share by about 13 cents in 2024, according to Bristol.
Read the full article here
-
Side Hustles6 days ago
How to Develop Empowered Leaders Within Your Own Team
-
Investing5 days ago
7 Marketing Strategies to Help Your Startup Grow and Scale
-
Side Hustles4 days ago
How to Be Unapologetically You and Why It Matters
-
Passive Income5 days ago
Are You Running Your Business, or Is Your Business Running You?
-
Side Hustles5 days ago
How Your Body Language Can Help Win a Disagreement
-
Side Hustles5 days ago
OpenAI Raises Record $6.6 Billion, Adds 50 Million New Users
-
Side Hustles6 days ago
Why the Best Time to Sell Your Business Is When You Least Expect It
-
Make Money5 days ago
FlexJobs Report: Here’s How Workers View AI and Job Stability